Search

everythinglearnresearchcommunity

for

Search:↓

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Finasteride effectively reduces prostate size in dogs with benign prostatic hyperplasia at a low, safe dose.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride may reduce prostate cancer risk.

Androgen, especially DHT, is crucial for erectile function in rats by affecting specific brain neurons.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

A rare non-cancerous tumor that grows like hair was found in an unusual spot, the vulva.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

A spayed dog with vaginal bone structures causing infection was successfully treated by removing the bones and administering medication.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.